Skip to Content
Merck

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism.

Science advances (2021-02-02)
Rasmus Pihl, Rasmus K Jensen, Emil C Poulsen, Lisbeth Jensen, Annette G Hansen, Ida B Thøgersen, József Dobó, Péter Gál, Gregers R Andersen, Jan J Enghild, Steffen Thiel
ABSTRACT

Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin-associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-ITIH4 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Kallikrein from human plasma, buffered aqueous solution, ≥5 units/mg protein